AKT1 and metabolic dysfunction-associated steatotic liver disease: Therefore, the modulation of mitophagy by manipulation of the PI3K/AKT/mTOR-dependent signaling pathway to eliminate damaged mitochondria may be a potential therapeutic approach for the management of NAFLD (66).